Incidence and evolution of viral retinitis in HIV-infected patients treated with HIV-protease inhibitors;Etude de l'incidence et de l'evolution des retinites virales chez les patients infectes par le VIH et traites par les inhibiteurs de protease du VIH

Journal Francais d'Ophtalmologie

Volumn 21, Issue 8, 1998, Pages 567-576

  Labetoulle, M ^a   Goujard, C ^a   Frau, E ^a   Rogier, H ^a   Niessen, F ^a   Rudent, A ^a   Lantz, O ^a   Lecointe, D ^a   Furlan, V ^a   Delfraissy, J F ^a   Offret, H ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

AIDS; Antiviral drugs; CMV retinitis; Cytomegalovirus; HIV; HIV Protease inhibitor; HIV related infection; Immunodeficiency; Necrotizing retinitis; Viral retinitis

Indexed keywords

PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTIOUS COMPLICATION; RELAPSE; RETINITIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; CYTOMEGALOVIRUS RETINITIS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; FUNDUS OCULI; HIV PROTEASE INHIBITORS; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; VIRAL LOAD;

EID: 7844245778     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Révision de la définition du sida en France. Bull Epidemiol Hebdo, 1993; 47-48.
2. Centers for diseases control - 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mortal Wkly Rep, 1992; 41:1-19.
3. HOLLAND G.N., PEPOSE J.S., PETTIT T.H., GOTTLIEB M.S., YEE R.D., FOOS R.Y. - Acquired immune deficiency syndrome. Ocular manifestations. Ophthalmology, 1983; 90:859-873.
4. REPOSE J.S., HOLLAND G.N., NESTOR M.S., COCHRAN A.J., FOOS R.Y. - Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease. Ophthalmology, 1985; 92:472-484.
5. JABS D.A., GREEN W.R., FOX R., POLK B.F., BARTLETT J.G. - Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology, 1989; 96:1092-1099.
6. LEHOANG P., GIRARD B., ROUSSELIE F. - Œil et Sida. Doin Editeurs, Paris, 1989.
7. PERTEL P., HIRSCHTICK R., PHAIR J., CHMIEL J., POGGENSEE L., MURPHY R. - Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr, 1992; 5:1069-1074.
8. KUPPERMANN B.D., PETTY J.G., RICHMAN D.D., et al. - Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol, 1993; 115:575-582.
9. COCHEREAU I., KOROBELNIK J.F., PETIT E., MATHERON S., LONGUET P., HOANG-XUAN T. - Pronostic du décollement de rétine sur rétinite à cytomégalovirus. J Fr Ophtalmol, 1995; 18:603-607.
10. CASSOUX N., REUX I., GUEX-CROSIER Y., LEHOANG P. - Manifestations rétiniennes du SIDA. Rev Prat, 1996; 46:1745-1749.
11. HO D.D., NEUMANN A.U., PERELSON A.S., CHEN W., LEONARD J.M., MARKOWITZ M. - Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature, 1995; 373:123-126.
12. WEI X., GHOSH S.K., TAYLOR M.E., JOHNSON V.A., EMINI E.A., DEUTSCH P., LIFSON J.D., BONHOEFFER S., NOWAK M.A., HAHN B.H., SAAG M.S., SHAW G.M. - Viral dynamics in human immunodeficiency virus type 1 infection. Nature, 1995; 373:117-122.
13. MOUTON Y., ALFANDARI S., VALETTE M., CARTIER F., DELLMONICA P., HUMBERT G., LANG J.M., MASSIP P., MECHALI D., LECLERCQ P., MODAI J., PORTIER H. - La Fédération Nationale des Centres de Lutte contre le SIDA - Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. AIDS, 1997; 11:F101-F105.
14. PALLELA F., MOORMAN A., DELANEY K., LOVELESS M., FUHRER J., ASCHMAN D., HOLMBERG S. - The HIV Outpatient Study (HOPS) Group - Declining morbidity and mortality in an ambulatory HIV-infected population. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, 28 September-01 October 1997, Abstract I-17.
15. SALMON-CERON D. - Prise en charge thérapeutique de la maladie à cytomégalovirus au cours de l'infection par le VIH. Du traitement curatif au traitement préemptif: acquis et incertitudes. Presse Med, 1998; 27:181-188.
16. DOAN S., BADELON I., CHAINE G. - Evolution de la rétinite à cytomégalovirus chez des patients HIV sous trithérapie antirétrovirale. J Fr Ophtalmol, 1998; 21:34-41.
17. BARIL L., JOUAN M., CAUMES E., MENGCAL X., BRICAIRE F., KATLAMA C. - The impact of active antiretroviral therapy on the incidence of CMV disease in AIDS patients. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, 28 September-01 October 1997, Abstract I-31.
18. MICHELET C., ALLAVENA C., BESNIER J., ROGEZ J.P., BREUX J.P., SOUALA F., GARRE M., CARTIER F. - The GERICCO Group - Opportunisitic infections occured under protease inhibitors in HIV patients. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, 28 september-01 October 1997, Abstract I-29.
19. Studies on ocular complications of AIDS (SOCA) research group, in collaboration with the AIDS clinical trial group (ACTG) - Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med, 1992; 326: 213-220.
20. SPECTOR S.A., WEINGEST T., POLLARD R.B., DIETERICH D.T., SAMO T., BENSON C.A., BUSH D.F., FREEMAN W.R., MONTAGUE P., KAPLAN H.J., KELLERMAN L., CRAGER M., DE ARMOND B., BUHLES W., FEINBERG J., AIDS CLINICAL TRIAL GROUP (ACTG), CYTOMEGALOVIRUS COOPERATIVE STUDY GROUP, WEINGEIST T., BUSCH D.F. - A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. J Infect Dis, 1993;168:557-563.
21. LEHOANG P., GIRARD B., ROBINET M., MARCEL P., ZAZOUN L., MATHERON S., ROZENBAUM W., KATLAMA C., MORER I., LERNESTEDT J.O., SARAUX H., POULIQUEN Y., GENTILINI M., ROUSSELIE F. - Foscarnet in the treatment of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology, 1989; 96:865-73; discussion 873-4.
22. COCHEREAU-MASSIN I., LEHOANG P., LAUTIER-FRAU M., ZAZOUN L., MARCEL P., ROBINET M., MATHERON S., KATLAMA C., GHARAKHANIAN S., ROZENBAUM W., INGRAND D., GENTILINI M. - Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology, 1991; 98:1348-53; discussion 1353.
23. DREW W.L., IVES D.V., LALEZARI J.P., CRUMPACKER C., FOLLANSBEE S.E., SPECTOR S.A., BENSON C.A., FRIEDBERG D.N., HUBBARD L., STEMPIEN M.J., SHADMAN A., BUHLES W., THE SYNTEX COOPERATIVE ORAL GANCICLOVIR STUDY GROUP. - Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. N Engl J Med, 1995; 333:615-620.
24. DANNER S.A., MATHERON S. - Cytomegalovirus retinitis in AIDS patients: a comparative study of intravenous and oral ganciclovir as maintenance therapy. AIDS, 1996; 10 (Suppl 4):S7-S11.
25. The oral ganciclovir european and australian cooperative study group - Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDS. The Oral Ganciclovir European and Australian Cooperative Study Group. AIDS, 1995; 9:471-477.
26. Studies on ocular complications of AIDS (SOCA) research group, in collaboration with the AIDS clinical trial group (ACTG) - Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Ann Intern Med, 1997; 126:264-274.
27. LALEZARI J.P., STAGG R.J., KUPPERMANN B.D., HOLLAND G.N., KRAMER F., IVES D.V., YOULE M., ROBINSON M.R., DREW W.L., JAFFE H.S. - Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial. Ann Intern Med, 1997; 126:257-263.
28. MARTIN D.F., PARKS D.J., MELLOW S.D., FERRIS F.L., WALTON R.C., REMALEY N.A., CHEW E.Y., ASHTON P., DAVIS M.D., NUSSENBLATT R.B. - Treatment of cytomegalovirus retinitis with an intraocular sustained- release ganciclovir implant. A randomized controlled clinical trial. Arch Ophthalmol, 1994; 112:1531-1539.
29. DUKER J.S., ROBINSON M., ANAND R., ASHTON P. - Initial experience with an eight-month sustained-release intravitreal ganciclovir implant for the treatment of CMV retinitis associated with AIDS. Ophthalmic Surg Lasers, 1995; 26:442-448.
30. FEKRAT S., DUNN J.P., LEE D., MILLER T., JABS D.A. - Cytomegalovirus retinitis in HIV-infected patients with elevated CD4+ counts. Arch Ophthalmol, 1995; 113:18.
31. BAGLIVO E., DOSSO A., LEUENBERGER P.M. - Cytomegalovirus retinitis in an AIDS patient without severe depletion in CD4 cell count. Br J Ophthalmol, 1995; 79:962-963.
32. CROWE S.M., CARLIN J.B., STEWART K.I., LUCAS C.R., HOY J.F. - Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr, 1991; 4:770-776.
33. HOCHSTER H., DIETERICH D.T., BOZZETTE S.A., REICHMAN R.C., CONNER J.P., LIEBES G., SONKE R.L., SPECTOR S.A., VALENTINE F., PETTINELLI C., RICHMAN D.D. - Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS: an AIDS Clinical Trial Group Study. Ann Intern Med, 1990; 113:111-117.
34. JACOBSON M.A., ZEGANS M., PAVAN P.R., O'DONNELL J.J., SATTLER F., RAO N., OWENS S., POLLARD R. - Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet, 1997; 349: 1443-1445.
35. GILQUIN J., PIKETTY C., THOMAS V., GONZALES-CANALI G., KAZATCHKINE M.D. - Acute CMV infection in AIDS patients receiving combination therapy including protease inhibitors. 4th Conference on retroviruses and opportunistic infections. Washington, D.C. 22-26 January 1997 Abstract 354.
36. AUTRAN B., CARCELAIN G., LI T.S., BLANC C., MATHEZ D., TUBIANA R., KATLAMA C., DEBRÉ P., LEIBOWITCH J. - Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science, 1997; 277:112-116.
37. GOROCHOV G., NEUMANN A.U., KEREVEUR A., PARIZOT C., LI T., KATLAMA C., KARMOCHKINE M., RAGUIN G., AUTRAN B., DEBRÉ P. - Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy. Nature Med, 1998; 4:215-221.
38. CHAMPAGNE P., LAVOIE P.M., SÉKALI R.P., YACHOU A. - L'infection par le VIH: importance des facteurs de l'hôte. Medecine/Science, 1998; 14:142-157.
39. PAKKER N.G., NOTERMANS D.W., DE BOER R.J., ROOS M.T.L., DE WOLF F., HILL A., LEONARD J.M., DANNER S.A., MIEDEMA F., SCHELLEKENS P.T.A. - Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nature Med, 1998; 4:208-214.